{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-26-001447","form_type":"8-K","ticker":"ACBM","cik":"0001622996","company_name":"ACRO BIOMEDICAL CO., LTD.","filed_at":"2026-09-02T20:05:24+00:00","discovered_at":"2026-09-02T20:06:00.415380+00:00","generated_at":"2026-09-02T20:06:19.472131+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Acro Biomedical appoints new chairman and CEO; Su resigns","bullets":["Yu-Ting Su resigned as director, chairman, and CEO on Sept 2, 2026, effective immediately.","Board appointed Shao-Hsiang Shih as director and chairman, effective Sept 2, 2026.","Jing-Zhou Chen appointed CEO and CFO, effective Sept 2, 2026.","Su's resignation was not due to any disagreement with the company."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-26-001447","json":"https://secwatch.observer/filing/0001640334-26-001447.json","markdown":"https://secwatch.observer/filing/0001640334-26-001447.md","text":"https://secwatch.observer/filing/0001640334-26-001447.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1622996/000164033426001447/0001640334-26-001447-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1622996/000164033426001447/acbm_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-02T20:06:19.472131+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}